Carregant...
Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies
BACKGROUND: The United States (US) Food and Drug Administration (FDA) is responsible for the protection of the public health by assuring the safety, effectiveness and security of human drugs and biological products through the enforcement of the Federal Food, Drug and Cosmetic Act (FDCA) and related...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3582490/ https://ncbi.nlm.nih.gov/pubmed/23339419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-13-27 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|